title: Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.
abstract: Anemia in chronic kidney disease is a prevalent and expensive problem in the United States, and it is well documented that anemia worsens as glomerular filtration rates decline. The complications of severe anemia in this patient population contribute significantly to their overall morbidity with increased cardiovascular complications, decreased quality of life, and increased dependence on transfusions to maintain adequate hemoglobin levels. Erythropoietin-stimulating agents (ESAs) have revolutionized the treatment of anemia in this population, but there has been a great deal of controversy surrounding the quest for the ideal hemoglobin target. In addition, there are economic and practice management implications where anemia treatment is concerned, with ongoing refinement of Centers for Medicare and Medicaid Services-bundled payments. One of the newest additions to the arsenal used to fight anemia in end-stage renal disease patients is peginesatide (Omontys), a synthetic, PEGylated, peptide-based ESA that acts by stimulating the erythropoietin receptor. The role of peginesatide in the future treatment of anemia in chronic kidney disease remains uncertain, with new safety concerns being brought to attention as it emerges on the market, prompting a national recall.
authors.affiliation: Division of Nephrology, University of Wisconsin, Madison, WI, USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Valliant
authors.forename: R Michael
authors.initials: RM
authors.lastname: Hofmann
mesh_terms: D000740:Anemia / Q000453:epidemiology* / Q000517:prevention & control*; D015897:Comorbidity; D019317:Evidence-Based Medicine; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D015995:Prevalence; D006435:Renal Dialysis / Q000706:statistics & numerical data*; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology* / Q000534:rehabilitation*; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D010455:Peptides; C556270:peginesatide
keywords: anemia; chronic kidney disease; peginesatide
references.citation: Blood. 2010 Apr 29;115(17):3616-24
references.pmid: 20053755
references.citation: Transplantation. 2010 Jul 27;90(2):168-74
references.pmid: 20463636
references.citation: Am J Kidney Dis. 2010 Jan;55(1):113-20
references.pmid: 19932539
references.citation: Med Lett Drugs Ther. 2012 Jun 11;54(1392):45-6
references.pmid: 22683926
references.citation: Am J Kidney Dis. 2003 Jan;41(1):266-7; author reply 267
references.pmid: 12500250
references.citation: Am J Kidney Dis. 2012 Mar;59(3):444-51
references.pmid: 22192713
references.citation: Exp Hematol. 2006 Oct;34(10):1303-11
references.pmid: 16982323
references.citation: N Engl J Med. 2013 Jan 24;368(4):320-32
references.pmid: 23343062
references.citation: Clin J Am Soc Nephrol. 2011 Nov;6(11):2579-86
references.pmid: 21940838
references.citation: Eur J Biochem. 1992 Dec 15;210(3):649-63
references.pmid: 1483451
references.citation: Recent Pat Cardiovasc Drug Discov. 2006 Jun;1(2):129-39
references.pmid: 18221080
references.citation: Blood Purif. 2008;26(6):537-46
references.pmid: 18997465
references.citation: J Am Soc Nephrol. 2010 Dec;21(12):2151-6
references.pmid: 21115615
references.citation: Kidney Int. 2008 Sep;74(6):791-8
references.pmid: 18596733
references.citation: Nephrol Dial Transplant. 2004 May;19 Suppl 2:ii1-47
references.pmid: 15206425
references.citation: FASEB J. 2003 Sep;17(12):1742-4
references.pmid: 12958195
references.citation: N Engl J Med. 2006 Nov 16;355(20):2085-98
references.pmid: 17108343
references.citation: Clin J Am Soc Nephrol. 2010 Apr;5(4):667-72
references.pmid: 20299366
references.citation: Nat Rev Mol Cell Biol. 2004 May;5(5):343-54
references.pmid: 15122348
references.citation: Exp Hematol. 2007 Aug;35(8):1201-8
references.pmid: 17662888
references.citation: Clin J Am Soc Nephrol. 2008 Jan;3(1):200-7
references.pmid: 18077782
references.citation: Nephrol Dial Transplant. 2010 Sep;25(9):2846-50
references.pmid: 20591813
references.citation: J Pharm Sci. 2004 May;93(5):1367-73
references.pmid: 15067712
references.citation: Blood. 2006 Sep 15;108(6):1830-4
references.pmid: 16720830
references.citation: Clin J Am Soc Nephrol. 2010 Sep;5(9):1681-9
references.pmid: 20724518
references.citation: Blood. 2004 Dec 15;104(13):4300-7
references.pmid: 15328158
references.citation: Science. 1996 Jul 26;273(5274):458-64
references.pmid: 8662529
references.citation: J Am Soc Nephrol. 2001 Nov;12(11):2465-2473
references.pmid: 11675424
references.citation: N Engl J Med. 2013 Jan 24;368(4):307-19
references.pmid: 23343061
references.citation: J Am Soc Nephrol. 2004 Dec;15(12):3154-65
references.pmid: 15579519
references.citation: N Engl J Med. 1998 Aug 27;339(9):584-90
references.pmid: 9718377
references.citation: J Am Soc Nephrol. 2008 Feb;19(2):372-9
references.pmid: 18216316
references.citation: Semin Nephrol. 2006 Jul;26(4):261-8
references.pmid: 16949463
references.citation: N Engl J Med. 2009 Nov 19;361(21):2019-32
references.pmid: 19880844
references.citation: Mayo Clin Proc. 2005 Oct;80(10):1270-7
references.pmid: 16212138
references.citation: Blood. 1991 Feb 1;77(3):419-34
references.pmid: 1991159
references.citation: FASEB J. 2002 Nov;16(13):1811-3
references.pmid: 12223449
references.citation: Blood Rev. 2010 Jan;24(1):39-47
references.pmid: 19833421
references.citation: Kidney Int. 2004 Mar;65(3):757-67
references.pmid: 14871396
references.citation: Am J Kidney Dis. 1996 Jul;28(1):53-61
references.pmid: 8712222
references.citation: N Engl J Med. 2009 Nov 5;361(19):1848-55
references.pmid: 19890127
references.citation: J Immunol. 1990 Jan 1;144(1):209-13
references.pmid: 2295792
references.citation: Am J Kidney Dis. 2007 Sep;50(3):471-530
references.pmid: 17720528
references.citation: Fed Regist. 2012 Nov 9;77(218):67450-531
references.pmid: 23139948
references.citation: N Engl J Med. 2006 Nov 16;355(20):2071-84
references.pmid: 17108342
references.citation: Vox Sang. 2008 Feb;94(2):87-95
references.pmid: 18034787